Office of Research Operations during COVID-19 Pandemic

Last Updated 4/1/2020

The Office of Research will continue to remain operational. Staff not directly associated with an essential service will work remotely. The safety and health of our research workforce and animals will remain our highest priority.

• Animal Care Program, including TRACS, will continue to operate.  Contingency plans are in place to ensure ongoing animal care and welfare in case of short staffing.   The Teaching and Research Animal Care Services will maintain their essential research support functions, although some lower-priority services may need to be curtailed (e.g., less frequent waste pick-up). For a more detailed description, visit our dedicated page.
• Human Research Protection Program (HRPP/IRB) will operate per normal schedule. Some staff may work remotely (with full access to IRB assets), but will be available via phone, email and videoconferencing as needed. A process for priority review of COVID-19 related protocols has been established. Submissions can be uploaded into IRBNet with “Covid” in the study title. In the event of emergency, please contact the IRB administration directly at 916.703.9146. For more information, visit our dedicated page on human subject research.
• IACUC will operate per normal schedule with the option of holding committee meetings virtually if the need arises.
• Innovation and Technology Commercialization including InnovationAccessand Venture Catalyst will operate per normal schedule. Some staff may work remotely, but will be available via phone, email and videoconferencing as needed.
• Research Compliance and Integrity will operate per normal schedule. Some staff may work remotely, but will be available via phone, email and videoconferencing as needed. Response times may be delayed in rare cases where access to onsite records or paper documents are required.
• Sponsored Programs Office (SPO) will operate per normal schedule. Staff may work remotely, but will be available via phone, email and videoconferencing as needed. Time sensitive opportunities for funding related to COVID-19 research such as the NSF RAPID program or NIH’s NOSI programs will receive heightened priority. Click here for more information on operations related to proposals an awards.

Related to COVID-19